Diamond
PharmaEssentiaTM
- FLASCO
- July 6, 2022
- No Comments
PharmaEssentia Corporation, based in Taipei, Taiwan, is a rapidly growing biopharmaceutical innovator. Leveraging deep expertise and proven scientific principles, the company aims to deliver effective new biologics for challenging diseases in the areas of hematology and oncology, with one approved product and a diversifying pipeline. Founded in 2003, the company is now expanding its global…
Caris Life Sciences
- FLASCO
- May 12, 2021
- No Comments
Caris Life Sciences® is a leading innovator in molecular science focused on fulfilling the promise of precision medicine through quality and innovation. The company’s suite of market-leading molecular profiling offerings assesses DNA, RNA and proteins to reveal a molecular blueprint that helps physicians and cancer patients make more precise and personalized treatment decisions. MI Exome™…
Regeneron
- FLASCO
- March 25, 2021
- No Comments
LIBTAYO Surround Product Website CSCC Study Results CSCC Patient Examples Patient Resources
Jazz Pharmaceuticals, Inc.
- FLASCO
- October 6, 2020
- No Comments
Jazz Pharmaceuticals plc (Nasdaq: JAZZ), a global biopharmaceutical company, is dedicated to developing medicines for people with limited or no options, so they can live their lives more fully and redefine what is possible. As a leader in sleep medicine and with a growing hematology/oncology portfolio, Jazz has a diverse portfolio of products and product…
Gilead
- FLASCO
- September 25, 2020
- No Comments
Gilead, is a leader in next generation antibody-drug conjugate (ADC) technology, committed to helping people with hard-to-treat cancers. The impossible is simply what hasn’t been achieved yet. Gilead’s research and development program is focused on what’s next. Their goal is to discover, identify and evaluate investigational compounds that show potential to advance the treatment of…
Daiichi Sankyo, Inc.
- FLASCO
- March 19, 2020
- No Comments
Daiichi Sankyo is dedicated to creating new modalities and innovative medicines by leveraging our world-class science and technology for our purpose “to contribute to the enrichment of quality of life around the world.” In addition to our current portfolio of medicines for cancer and cardiovascular disease, Daiichi Sankyo is primarily focused on developing novel therapies…
BeiGene
- Katrina Williams
- November 13, 2019
- No Comments
BeiGene is a global, commercial-stage biotechnology company focused on discovering, developing, manufacturing, and commercializing innovative medicines to improve treatment outcomes and access for patients worldwide. Our 5,400+ employees around the world are committed to expediting the development of a diverse pipeline of novel therapeutics. BeiGene: Blood Cancer Has No Borders, Neither Do We: https://youtu.be/UUoKZYigazk More…
Pharmacyclics
- FLASCO
- July 16, 2015
- No Comments
For more information about Pharmacyclics LLC, an AbbVie Company, please visit pharmacyclics.com.
Foundation Medicine
- FLASCO
- February 20, 2015
- No Comments
Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient’s unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and…
Boehringer Ingelheim
- FLASCO
- January 13, 2015
- No Comments
Boehringer Ingelheim in Oncology Cancer takes. Takes away time. Takes away loved ones. At Boehringer Ingelheim Oncology, we are giving patients new hope, by taking cancer on. We are dedicated to collaborating with the oncology community on a shared journey to deliver leading science. Our primary focus is in lung and gastrointestinal cancers, with the…